RAYMOND DWEK - 26 May 2022 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr., under Power of Attorney
Issuer symbol
UTHR
Transactions as of
26 May 2022
Net transactions value
-$804,400
Form type
4
Filing time
26 May 2022, 19:01:40 UTC
Previous filing
06 May 2022
Next filing
11 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UTHR Common Stock Options Exercise $319,500 +5,000 +250% $63.90 7,000 26 May 2022 Direct F1
transaction UTHR Common Stock Disposed to Issuer $1,123,900 -5,000 -71% $224.78 2,000 26 May 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Share Tracking Award Options Exercise $0 -5,000 -33% $0.000000 10,000 26 May 2022 Common Stock 5,000 $63.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.
F2 Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock.